CareDx Reports Second Quarter 2024 Results and Increases Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
CareDx, Inc (CDNA) PT Raised to $30 at Jefferies
August 1, 2024 7:01 AM EDTJefferies analyst Tycho Peterson raised the price target on CareDx, Inc (NASDAQ: CDNA) to $30.00 (from $17.00) while maintaining a Buy rating.
The analyst comments "CDNA's 2Q revenues significantly beat expectations, even when normalizing for prior period adjustments (+16% above). FY revenue guidance also marched... More
